Equate

Public Advisory - Equate (lemon flavour), Personnelle (lemon flavour) and Life Brand (lemon and cherry flavours) Magnesium citrate oral solution saline laxatives recalled due to potential microbial contamination

Retrieved on: 
Sunday, July 24, 2022
Pain scale, Diarrhea, NPN, Shoppers Drug Mart, Magnesium, Health, Health Canada, Immune system, Canada, Nausea, Pregnancy, Department, Pain, Vomiting, Salt, Dietary supplement, Motor vehicle, Personnel economics, Equate

Equate Magnesium citrate oral solution saline laxative, 300 mL, lemon flavour

Key Points: 
  • Equate Magnesium citrate oral solution saline laxative, 300 mL, lemon flavour
    Life Brand Magnesium citrate oral solution saline laxative, 300 mL, lemon flavour
    Life Brand Magnesium citrate oral solution saline laxative, 300 mL, cherry flavour
    Personnelle Magnesium citrate oral solution saline laxative, 300 mL, lemon flavour
    Health Canada is advising that all lots of Equate (lemon flavour), Life Brand (lemon and cherry flavours) and Personnelle (lemon flavour) Magnesium citrate oral solution saline laxative (NPN 80015316) are being recalled by the importer, Shandex Sales Group Ltd. (Shandex Group), due to the possibility of microbial contamination.
  • Magnesium citrate oral solution is used as a laxative for relief of occasional constipation.
  • Microbial testing of the products recalled in the U.S. identified the presence of Gluconacetobacter liquefaciens.
  • Children, pregnant women, the elderly and people with a weakened immune system may be more susceptible to serious adverse effects from microbial contamination.

Equillium Announces Multiple Abstracts Accepted for Presentation at the Transplantation & Cellular Meetings of ASTCT and CIBMTR

Retrieved on: 
Monday, January 10, 2022
Oncology, Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Diarrhea, SEC, Safety, Trial of the century, Risk, Itch, Semipermeable membrane, Nausea, Pharmacokinetics, McMillan, GVHD, Cancer, Patient, Vomiting, Association, Research, Adult, Rash, Center for International Blood and Marrow Transplant Research, Degenerative disease, Asthma, Irritation, Jaundice, Center, Program, Steroid, Serum, Salt Palace, Transplant, Skin discoloration, Partnership, Private Securities Litigation Reform Act, HSCT, Nasdaq, Feedback, 2021 Essex County Council election, Disease, CD6, EQUIP, Equate, Society, Mortality, Pharmaceutical industry, Vaccine, Efficacy, Itolizumab

The hybrid meetings will take place virtually and in person at the Salt Palace Convention Center in Salt Lake City, February 2 6, 2022.

Key Points: 
  • The hybrid meetings will take place virtually and in person at the Salt Palace Convention Center in Salt Lake City, February 2 6, 2022.
  • Symptoms of GVHD include rash, itching, skin discoloration, nausea, vomiting, diarrhea, and jaundice, as well as eye dryness and irritation.
  • Equillium is currently developing itolizumab for multiple severe immuno-inflammatory diseases, including acute graft-versus-host-disease (aGVHD) and lupus/lupus nephritis.
  • Equillium undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

EQUATE Group Announces Official Start-Up of MEGlobal Oyster Creek, TX Site

Retrieved on: 
Monday, October 14, 2019
Commodity chemicals, Chemistry, Physical sciences, Organic compounds, Oyster Creek, Ethylene glycol, Equate, Petrochemical, Oyster, Ethylene

OYSTER CREEK, Texas, Oct. 14, 2019 /PRNewswire/ -- Today the EQUATE Group is proud to announce the official start-up of the MEGlobal Oyster Creek Site's commercial production of fiber-grade, on-spec monoethylene glycol.

Key Points: 
  • OYSTER CREEK, Texas, Oct. 14, 2019 /PRNewswire/ -- Today the EQUATE Group is proud to announce the official start-up of the MEGlobal Oyster Creek Site's commercial production of fiber-grade, on-spec monoethylene glycol.
  • The new plant will be operated by MEGlobal Americas Inc., a subsidiary of EQUATE Petrochemical Company and is the Group's first manufacturing facility in the United States.
  • From safety to schedule to cost control, the MEGlobal Oyster Creek Site epitomizes our commitment to operational excellence and efficiency in order to serve the growing customer need for EG across the globe."
  • The MEGlobal Oyster Creek plant is leveraging the U.S. shale gas advantage by utilizing ethylene from the Dow Oyster Creek facility.

EQUATE Group announces inauguration of MEGlobal Oyster Creek, TX site

Retrieved on: 
Tuesday, September 10, 2019
Equate, Oyster Creek, Petrochemical

OYSTER CREEK, Texas, Sept. 9, 2019 /PRNewswire/ --Today the EQUATE Group is proud to announce the inauguration of its new MEGlobal Oyster Creek site in Oyster Creek, Texas, USA.

Key Points: 
  • OYSTER CREEK, Texas, Sept. 9, 2019 /PRNewswire/ --Today the EQUATE Group is proud to announce the inauguration of its new MEGlobal Oyster Creek site in Oyster Creek, Texas, USA.
  • "This is a major achievement for the EQUATE Group and will benefit both Kuwait and the U.S.," said EQUATE President and CEO Dr. Ramesh Ramachandran.
  • The EQUATE Group includes EQUATE Petrochemical Company (EQUATE), The Kuwait Olefins Company (TKOC), as well as a number of subsidiaries such as MEGlobal and Equipolymers.
  • As a subsidiary of EQUATE Petrochemical Company (EQUATE), MEGlobal is part of the EQUATE Group which is the world's second largest producer of EG.